{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:14:30Z","timestamp":1791994470986,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuropathology and neuroimaging studies have identified several subtypes of Alzheimer\u2019s disease (AD): hippocampal sparing AD, typical AD, and limbic predominant AD. An unresolved question is whether hippocampal sparing AD cases can present with neurofibrillary tangles (NFT) in association cortices while completely sparing the hippocampus. To address that question, we conducted a systematic review and performed original analyses on tau positron emission tomography (PET) data. We searched EMBASE, PubMed, and Web of Science databases until October 2022. We also implemented several methods for AD subtyping on tau PET to identify hippocampal sparing AD cases. Our findings show that seven out of the eight reviewed neuropathologic studies included cases at Braak stages IV or higher and therefore, could not identify hippocampal sparing cases with NFT completely sparing the hippocampus. In contrast, tau PET did identify AD participants with tracer retention in the association cortex while completely sparing the hippocampus. We conclude that tau PET can identify hippocampal sparing AD cases with NFT completely sparing the hippocampus. Based on the accumulating data, we suggest two possible pathways of tau spread: (1) a canonical pathway with early involvement of transentorhinal cortex and subsequent involvement of limbic regions and association cortices, and (2) a less common pathway that affects association cortices with limbic involvement observed at end stages of the disease or not at all.<\/jats:p>","DOI":"10.1186\/s40478-022-01471-z","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:16:09Z","timestamp":1668438969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The hippocampal sparing subtype of Alzheimer\u2019s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-4338","authenticated-orcid":false,"given":"Daniel","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaleena","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer\u2019s disease: a systematic review and meta-analysis. Neurology 94:436\u2013448","journal-title":"Neurology"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-radford","year":"2021","unstructured":"Graff-radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC et al (2021) New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol 20:222\u2013234","journal-title":"Lancet Neurol"},{"key":"1471_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biopsych.2020.01.016","volume":"88","author":"M Habes","year":"2020","unstructured":"Habes M, Grothe MJ, Tunc B, Mcmillan C, Wolk DA, Davatzikos C (2020) Disentangling heterogeneity in Alzheimer\u2019s disease and related dementias using data-driven methods. Biol Psychiatry 88:70\u201382","journal-title":"Biol Psychiatry"},{"key":"1471_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","volume":"77","author":"FS Hanna Al-Shaikh","year":"2020","unstructured":"Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM et al (2020) Selective vulnerability of the nucleus basalis of meynert among neuropathologic subtypes of alzheimer disease. JAMA Neurol 77:225\u2013233","journal-title":"JAMA Neurol"},{"key":"1471_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000508625","volume":"49","author":"KA Jellinger","year":"2021","unstructured":"Jellinger KA (2021) Pathobiological subtypes of alzheimer disease. Dement Geriatr Cogn Disord 49:321\u2013333","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1471_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/JAD-190264","volume":"71","author":"A Charil","year":"2019","unstructured":"Charil A, Shcherbinin S, Southekal S, Devous MD, Mintun M, Murray ME et al (2019) Tau subtypes of Alzheimer\u2019s disease determined in vivo using flortaucipir PET imaging. J Alzheimer\u2019s Dis 71:1037\u20131048","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1471_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785\u2013796","journal-title":"Lancet Neurol"},{"key":"1471_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/braincomms\/fcaa192","volume":"2","author":"R Mohanty","year":"2020","unstructured":"Mohanty R, M\u00e5rtensson G, Poulakis K, Muehlboeck J-S, Rodriguez-Vieitez E, Chiotis K et al (2020) Comparison of subtyping methods for neuroimaging studies in Alzheimer\u2019s disease: a call for harmonization. Brain Commun 2:192","journal-title":"Brain Commun"},{"key":"1471_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","volume":"11","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML et al (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: a case-control study. Lancet Neurol 11:868\u2013877","journal-title":"Lancet Neurol"},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1471_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.25142","volume":"83","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML et al (2018) [18F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer\u2019s disease. Ann Neurol 83:248\u2013257","journal-title":"Ann Neurol"},{"key":"1471_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jamaneurol.2022.0676","volume":"79","author":"CB Young","year":"2022","unstructured":"Young CB, Winer JR, Younes K, Cody KA, Betthauser TJ, Johnson SC et al (2022) Divergent cortical tau positron emission tomography patterns among patients with preclinical alzheimer disease. JAMA Neurol 79:592\u2013603","journal-title":"JAMA Neurol"},{"key":"1471_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","volume":"15","author":"SG Mueller","year":"2005","unstructured":"Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W et al (2005) The Alzheimer\u2019s disease neuroimaging initiative. Neuroimaging Clin N Am 15:869\u2013877","journal-title":"Neuroimaging Clin N Am"},{"key":"1471_CR14","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1093\/brain\/awz268","volume":"142","author":"CR Jack","year":"2019","unstructured":"Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS et al (2019) The bivariate distribution of amyloid-\u03b2 and tau: Relationship with established neurocognitive clinical syndromes. Brain 142:3230\u20133242","journal-title":"Brain"},{"key":"1471_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142756","volume":"10","author":"MS Byun","year":"2015","unstructured":"Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK et al (2015) Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer\u2019s disease. PLoS ONE 10:e0142756","journal-title":"PLoS ONE"},{"key":"1471_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack","year":"2017","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS et al (2017) Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimer\u2019s Dement 13:205\u2013216","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2967\/jnumed.120.245423","volume":"62","author":"D Tudorascu","year":"2021","unstructured":"Tudorascu D, Ikonomovic MD, Burnham S, Minhas D, Pascoal TA, Mason NS et al (2021) What Is T+? A gordian knot of tracers, thresholds, and topographies. J Nucl Med 62:614\u2013619","journal-title":"J Nucl Med"},{"key":"1471_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, Neil JPO, Ossenkoppele R, Baker SL et al (2016) PET imaging of tau deposition in the aging human brain Michael. Neuron 89:971\u2013982","journal-title":"Neuron"},{"key":"1471_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La R et al (2017) Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease. Neuroimage 157:448\u2013463","journal-title":"Neuroimage"},{"key":"1471_CR20","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","volume":"89","author":"SL Risacher","year":"2017","unstructured":"Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ et al (2017) Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology 89:2176\u20132186","journal-title":"Neurology"},{"key":"1471_CR21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E et al (2019) Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge. Mol Psychiatry 24:1112\u20131134","journal-title":"Mol Psychiatry"},{"key":"1471_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT et al (2021) Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med 27:871\u2013881","journal-title":"Nat Med"},{"key":"1471_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fninf.2013.00049","volume":"7","author":"J-S Muehlboeck","year":"2014","unstructured":"Muehlboeck J-S, Westman E, Simmons A (2014) TheHiveDB image data management and analysis framework. Front Neuroinform 7:49","journal-title":"Front Neuroinform"},{"key":"1471_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3233\/JAD-180169","volume":"64","author":"A Sahoo","year":"2018","unstructured":"Sahoo A, Bejanin A, Murray ME, Tosakulwong N, Weigand SD, Serie AM et al (2018) TDP-43 and Alzheimer\u2019s disease pathologic subtype in non-amnestic Alzheimer\u2019s disease dementia. J Alzheimer\u2019s Dis 64:1227\u20131233","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1471_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","volume":"138","author":"C Petersen","year":"2019","unstructured":"Petersen C, Nolan AL, de Paula-Fran\u00e7a-Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML et al (2019) Alzheimer\u2019s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol 138:597\u2013612","journal-title":"Acta Neuropathol"},{"key":"1471_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/trc2.12165","volume":"7","author":"M Uretsky","year":"2021","unstructured":"Uretsky M, Gibbons LE, Mukherjee S, Trittschuh EH, Fardo DW, Boyle PA et al (2021) Longitudinal cognitive performance of Alzheimer\u2019s disease neuropathological subtypes. Alzheimer\u2019s Dement Transl Res Clin Interv 7:1\u201313","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"1471_CR27","doi-asserted-by":"publisher","first-page":"E506","DOI":"10.1212\/WNL.0000000000013107","volume":"98","author":"DS Smirnov","year":"2022","unstructured":"Smirnov DS, Salmon DP, Galasko D, Goodwill VS, Hansen LA, Zhao Y et al (2022) Association of neurofibrillary tangle distribution with age at onset-related clinical heterogeneity in Alzheimer disease. Neurology 98:E506-517","journal-title":"Neurology"},{"key":"1471_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0531-5565(00)00147-9","volume":"35","author":"EH Corder","year":"2000","unstructured":"Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B (2000) Density profiles of Alzheimer disease regional brain pathology for the Huddinge brain bank: Pattern recognition emulates and expands upon Braak staging. Exp Gerontol 35:851\u2013864","journal-title":"Exp Gerontol"},{"key":"1471_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M et al (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539\u20131550","journal-title":"Brain"},{"key":"1471_CR30","first-page":"221","volume":"10","author":"AJ Schwarz","year":"2018","unstructured":"Schwarz AJ, Shcherbinin S, Slieker LJ, Risacher SL, Charil A, Irizarry MC et al (2018) Topographic staging of tau positron emission tomography images. Alzheimer\u2019s Dement Diagnosis Assess Dis Monit 10:221\u2013231","journal-title":"Alzheimer\u2019s Dement Diagnosis Assess Dis Monit"},{"key":"1471_CR31","first-page":"1","volume":"8","author":"JB Toledo","year":"2022","unstructured":"Toledo JB, Liu H, Grothe MJ, Rashid T, Launer L et al (2022) Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer\u2019s disease continuum. Alzheimer\u2019s Dement 8:1\u201314","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR32","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/mds.28624","volume":"36","author":"C Palleis","year":"2021","unstructured":"Palleis C, Brendel M, Finze A, Weidinger E, B\u00f6tzel K, Danek A et al (2021) Cortical [18F]PI-2620 binding differentiates corticobasal syndrome subtypes. Mov Disord 36:2104\u20132115","journal-title":"Mov Disord"},{"key":"1471_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/biom12030458","volume":"12","author":"M Rullmann","year":"2022","unstructured":"Rullmann M, Brendel M, Schroeter M, Saur D, Levin J, Perneczky R et al (2022) Multicenter F-18-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer\u2019s disease. Biomolecules 12:458","journal-title":"Biomolecules"},{"key":"1471_CR34","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3233\/JAD-215558","volume":"88","author":"N Krishnadas","year":"2022","unstructured":"Krishnadas N, Huang K, Schultz SA, Dor\u00e9 V, Bourgeat P, Goh AMY et al (2022) Visually identified Tau 18F-MK6240 PET patterns in symptomatic Alzheimer\u2019s disease. J Alzheimers Dis 88:1627\u20131637","journal-title":"J Alzheimers Dis"},{"issue":"Suppl.4","key":"1471_CR35","doi-asserted-by":"publisher","first-page":"e037181","DOI":"10.1002\/alz.037181","volume":"16","author":"D Ferreira","year":"2020","unstructured":"Ferreira D (2020) A conceptual framework for future studies on subtypes of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 16(Suppl.4): e037181. https:\/\/doi.org\/10.1002\/alz.037181","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR36","doi-asserted-by":"crossref","unstructured":"Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, et al (2020) Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci Adv 6:eabd1327","DOI":"10.1126\/sciadv.abd1327"},{"key":"1471_CR37","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimer\u2019s Dement 17:1554\u20131574","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR38","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak H, Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain 138:2814\u20132833","journal-title":"Brain"},{"key":"1471_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10548-012-0246-x","volume":"26","author":"E Westman","year":"2013","unstructured":"Westman E, Aguilar C, Muehlboeck JS, Simmons A (2013) Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer\u2019s disease and mild cognitive impairment. Brain Topogr 26:9\u201323","journal-title":"Brain Topogr"},{"key":"1471_CR40","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.1038\/s41598-018-29927-0","volume":"8","author":"G M\u00e5rtensson","year":"2018","unstructured":"M\u00e5rtensson G, Pereira JB, Mecocci P, Vellas B, Tsolaki M, K\u0142oszewska I et al (2018) Stability of graph theoretical measures in structural brain networks in Alzheimer\u2019s disease. Sci Rep 8:11592","journal-title":"Sci Rep"},{"key":"1471_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/hipo.22721","volume":"27","author":"D Ferreira","year":"2017","unstructured":"Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hern\u00e1ndez-Cabrera JA et al (2017) The interactive effect of demographic and clinical factors on hippocampal volume: a multicohort study on 1958 cognitively normal individuals. Hippocampus 27:653\u2013667","journal-title":"Hippocampus"},{"key":"1471_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG et al (2017) AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81:58\u201367","journal-title":"Ann Neurol"},{"key":"1471_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27603","volume":"34","author":"Z Nedelska","year":"2019","unstructured":"Nedelska Z, Josephs KA, Graff-Radford J, Przybelski SA, Lesnick TG, Boeve BF et al (2019) 18 F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy. Mov Disord 34:344\u2013352","journal-title":"Mov Disord"},{"key":"1471_CR44","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1038\/s41598-018-23041-x","volume":"8","author":"R Smith","year":"2018","unstructured":"Smith R, Sch\u00f6ll M, Londos E, Ohlsson T, Hansson O (2018) 18F-AV-1451 in Parkinson\u2019s Disease with and without dementia and in Dementia with Lewy Bodies. Sci Rep 8:4717","journal-title":"Sci Rep"},{"key":"1471_CR45","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"S Gomperts","year":"2016","unstructured":"Gomperts S (2016) Tau PET imaging in the Lewy body diseases. JAMA Neurol 73:1334\u20131341","journal-title":"JAMA Neurol"},{"key":"1471_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mds.27252","volume":"33","author":"SH Lee","year":"2018","unstructured":"Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS et al (2018) Distinct patterns of amyloid-dependent tau accumulation in lewy body diseases. Mov Disord 33:262\u2013272","journal-title":"Mov Disord"},{"key":"1471_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","volume":"96","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K et al (2020) Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiol Aging 96:137\u2013147","journal-title":"Neurobiol Aging"},{"key":"1471_CR48","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"I McKeith","year":"2017","unstructured":"McKeith I, Dickson DW, Lowe J, Halliday G, Taylor J-P, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"1471_CR49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2016.07.003","volume":"13","author":"L Sarro","year":"2017","unstructured":"Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG et al (2017) An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimer\u2019s Dement 13:257\u2013266","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR50","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","volume":"21","author":"I Gungor","year":"2015","unstructured":"Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA et al (2015) Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Park Relat Disord 21:1101\u20131104","journal-title":"Park Relat Disord"},{"key":"1471_CR51","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.neurobiolaging.2015.03.007","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA et al (2015) White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol Aging 36:2010\u20132017","journal-title":"Neurobiol Aging"},{"key":"1471_CR52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nicl.2018.06.020","volume":"19","author":"Z Nedelska","year":"2018","unstructured":"Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF et al (2018) Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET. NeuroImage Clin 19:939\u2013947","journal-title":"NeuroImage Clin"},{"key":"1471_CR53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jalz.2018.09.011","volume":"15","author":"K Oppedal","year":"2019","unstructured":"Oppedal K, Ferreira D, Cavallin L, Lemstra A, ten Kate M, Padovani A et al (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from The European DLB Consortium. Alzheimer\u2019s Dement 15:400\u2013409","journal-title":"Alzheimer\u2019s Dement"},{"key":"1471_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-011-0889-9","volume":"123","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathological subtypes of Alzheimer\u2019s disease. Acta Neuropathol 123:153\u2013154","journal-title":"Acta Neuropathol"},{"key":"1471_CR55","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.24493","volume":"78","author":"KA Josephs","year":"2015","unstructured":"Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Liesinger AM et al (2015) TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features. Ann Neurol 78:697\u2013709","journal-title":"Ann Neurol"},{"key":"1471_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-020-00620-7","volume":"12","author":"A Machado","year":"2020","unstructured":"Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L et al (2020) The cholinergic system and treatment response in subtypes of Alzheimer\u2019s disease. Alzheimers Res Ther 12:51","journal-title":"Alzheimers Res Ther"},{"key":"1471_CR57","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp.2004.043539","volume":"76","author":"P Connelly","year":"2005","unstructured":"Connelly P, Prentice N, Fowler K (2005) Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 76:320\u2013324","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1471_CR58","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","volume":"356","author":"I McKeith","year":"2000","unstructured":"McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 356:2031\u20132036","journal-title":"Lancet"},{"key":"1471_CR59","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1093\/brain\/aws173","volume":"135","author":"K Kantarci","year":"2012","unstructured":"Kantarci K, Petersen RC, Knopman DS, Przybelski S, Lesnick TG, Senjem ML et al (2012) Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Brain 135:2470\u20132477","journal-title":"Brain"},{"key":"1471_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-012-1044-y","volume":"124","author":"NJ Janocko","year":"2012","unstructured":"Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R et al (2012) Neuropathologically defined subtypes of Alzheimer\u2019s disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681\u2013692","journal-title":"Acta Neuropathol"},{"key":"1471_CR61","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1212\/WNL.0000000000008679","volume":"94","author":"L Yu","year":"2020","unstructured":"Yu L, Boyle PA, Dawe RJ, Bennett DA, Arfanakis K, Schneider JA (2020) Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology 94:e142-152","journal-title":"Neurology"},{"key":"1471_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2018.05.028","volume":"70","author":"D Ferreira","year":"2018","unstructured":"Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T et al (2018) The contribution of small vessel disease to subtypes of Alzheimer\u2019s disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiol Aging 70:18\u201329","journal-title":"Neurobiol Aging"},{"key":"1471_CR63","doi-asserted-by":"publisher","unstructured":"Mohanty R, Ferreira D, Nordberg A, Westman E (2021) Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer\u2019s disease continuum. medRxiv. https:\/\/doi.org\/10.1101\/2021.08.10.21261824v1","DOI":"10.1101\/2021.08.10.21261824v1"},{"key":"1471_CR64","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1212\/WNL.0000000000200573","volume":"99","author":"R Mohanty","year":"2022","unstructured":"Mohanty R, Ferreira D, Frerich S, Muehlboeck J-S, Grothe MJ, Westman E (2022) Neuropathologic features of antemortem atrophy-based subtypes of Alzheimer disease. Neurology 99:e323\u2013e333","journal-title":"Neurology"},{"key":"1471_CR65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jalz.2019.08.201","volume":"16","author":"R Ossenkoppele","year":"2020","unstructured":"Ossenkoppele R, Hyoung C, Sudre CH, Van WD, Cho H, Hoon Y et al (2020) Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer\u2019s disease. Alzheimers Dement 16:335\u2013344","journal-title":"Alzheimers Dement"},{"key":"1471_CR66","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1038\/s41467-022-32202-6","volume":"13","author":"K Poulakis","year":"2022","unstructured":"Poulakis K, Pereira J, Muehlboeck J-S, Wahlund L-O, Smedby \u00d6, Volpe G et al (2022) Stage vs. Subtype hypothesis in Alzheimer\u2019s disease: a multi-cohort and longitudinal Bayesian clustering study. Nat Commun 13:4566","journal-title":"Nat Commun"},{"key":"1471_CR67","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1093\/brain\/awaa180","volume":"143","author":"TA Pascoal","year":"2020","unstructured":"Pascoal TA, Therriault J, Benedet AL, Savard M, Lussier FZ, Chamoun M et al (2020) 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain 143:2818\u20132830","journal-title":"Brain"},{"key":"1471_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-210614","volume":"84","author":"E Colato","year":"2021","unstructured":"Colato E, Chiotis K, Ferreira D, Mazrina MS, Lemoine L, Mohanty R et al (2021) Assessment of tau pathology as measured by 18F-THK5317 and 18F-flortaucipir PET and their relation to brain atrophy and cognition in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 84:103\u2013117","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1471_CR69","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","volume":"48","author":"A Leuzy","year":"2021","unstructured":"Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N et al (2021) A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging 48:2295\u20132305","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1471_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40478-015-0187-1","volume":"3","author":"T Arendt","year":"2015","unstructured":"Arendt T, Br\u00fcckner MK, Morawski M, J\u00e4ger C, Gertz H-J (2015) Early neurone loss in Alzheimer\u2019s disease: cortical or subcortical? Acta Neuropathol Commun 3:101\u2013111","journal-title":"Acta Neuropathol Commun"},{"key":"1471_CR71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-020-02248-1","volume":"141","author":"BJ Matchett","year":"2021","unstructured":"Matchett BJ, Grinberg LT, Theofilas P, Murray ME (2021) The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 141:631\u2013650","journal-title":"Acta Neuropathol"},{"key":"1471_CR72","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC et al (2020) Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat Commun 11:2612","journal-title":"Nat Commun"},{"key":"1471_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1440-1789.2000.00284.x","volume":"20","author":"RA Armstrong","year":"2000","unstructured":"Armstrong RA, Nochlin D, Bird TD (2000) Neuropathological heterogeneity in Alzheimer\u2019s disease: a study of 80 cases using principal components analysis. Neuropathology 20:31\u201337","journal-title":"Neuropathology"},{"key":"1471_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000106882","volume":"7","author":"RA Armstrong","year":"1996","unstructured":"Armstrong RA, Wood L, Myers D, Smith CUM (1996) The use of multivariate methods in the identification of subtypes of alzheimer\u2019s disease: a comparison of principal components and cluster analysis. Dement Geriatr Cogn Disord 7:215\u2013220","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1471_CR75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF00294360","volume":"88","author":"RA Armstrong","year":"1994","unstructured":"Armstrong RA, Wood L (1994) The identification of pathological subtypes of Alzheimer\u2019s disease using cluster analysis. Acta Neuropathol 88:60\u201366","journal-title":"Acta Neuropathol"},{"key":"1471_CR76","first-page":"1","volume":"11","author":"RA Armstrong","year":"1992","unstructured":"Armstrong RA, Myers D (1992) Principal components analysis of Alzheimer\u2019s disease based on neuropathological data: a study of 79 patients. Neurosci Res Commun 11:1\u20139","journal-title":"Neurosci Res Commun"},{"key":"1471_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-131241","volume":"39","author":"R Blennerhassett","year":"2014","unstructured":"Blennerhassett R, Lillo P, Halliday GM, Hodges JR (2014) Distribution of pathology in frontal variant Alzheimer\u2019s disease. J Alzheimers Dis 39:63\u201370","journal-title":"J Alzheimers Dis"},{"key":"1471_CR78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/archpsyc.1993.01820170028004","volume":"50","author":"W Bondareff","year":"1993","unstructured":"Bondareff W et al (1993) Evidence of subtypes of Alzheimer\u2019s disease and implications for etiology. Arch Gen Psychiatry 50:350\u2013356","journal-title":"Arch Gen Psychiatry"},{"key":"1471_CR79","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0197-4580(92)90085-C","volume":"13","author":"PD Coleman","year":"1992","unstructured":"Coleman PD, Kazee AM, Lapham L, Eskin T, Rogers K (1992) Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer\u2019s disease. Neurobiol Aging 13:631\u2013639","journal-title":"Neurobiol Aging"},{"key":"1471_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JAD-2010-1205","volume":"19","author":"C Cupidi","year":"2010","unstructured":"Cupidi C, Capobianco R, Goffredo D, Marcon G, Ghetti B (2010) Neocortical variation of A\u03b2 load in fully expressed, pure Alzheimer\u2019s disease. J Alzheimers Dis 19:57\u201368","journal-title":"J Alzheimers Dis"},{"key":"1471_CR81","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ana.26233","volume":"90","author":"SR Das","year":"2021","unstructured":"Das SR et al (2021) Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer\u2019s disease. Ann Neurol 90:751\u2013762","journal-title":"Ann Neurol"},{"key":"1471_CR82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/NEN.0000000000000028","volume":"73","author":"BN Dugger","year":"2014","unstructured":"Dugger BN et al (2014) Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol 73:72\u201380","journal-title":"J Neuropathol Exp Neurol"},{"key":"1471_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0306-4522(94)90546-0","volume":"63","author":"M Holzer","year":"1994","unstructured":"Holzer M, Zedlick D, Bruckner MK (1994) Abnormally phosphorylated tau protein in Alzheimer\u2019s disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63:499\u2013516","journal-title":"Neuroscience"},{"key":"1471_CR84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fnagi.2019.00211","volume":"11","author":"S Jeon","year":"2019","unstructured":"Jeon S et al (2019) Topographical heterogeneity of Alzheimer\u2019s disease based on MR imaging, tau PET, and amyloid PET. Front Aging Neurosci 11:211","journal-title":"Front Aging Neurosci"},{"key":"1471_CR85","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1474-4422(12)70209-0","volume":"11","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG (2012) Clinical stratification of subtypes of Alzheimer\u2019s disease. Lancet Neurol 11:839\u2013841","journal-title":"Lancet Neurol"},{"key":"1471_CR86","doi-asserted-by":"crossref","first-page":"e12326","DOI":"10.1002\/dad2.12326","volume":"14","author":"N Krishnadas","year":"2022","unstructured":"Krishnadas N et al (2022) Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases. Alzheimers Dement (Amst) 14:e12326","journal-title":"Alzheimers Dement (Amst)"},{"key":"1471_CR87","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ et al (2018) Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia. Brain 141:271\u2013287","journal-title":"Brain"},{"key":"1471_CR88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1046\/j.1440-1789.2003.00514.x","volume":"23","author":"Y Mizuno","year":"2003","unstructured":"Mizuno Y, Ikeda K, Tsuchiya K, Ishihara R, Shibayama H (2003) Two distinct subgroups of senile dementia of Alzheimer type: quantitative study of neurofibrillary tangles. Neuropathology 23:282\u2013289","journal-title":"Neuropathology"},{"key":"1471_CR89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1440-1789.1994.tb00244.x","volume":"14","author":"T Mizutani","year":"1994","unstructured":"Mizutani T (1994) Neuropathological diagnosis of senile dementia of the Alzheimer type (SDAT): proposal of diagnostic criteria and report of the Japanese Research Meeting on Neuropathological Diagnosis of SDAT. Neuropathology 14:91\u2013103","journal-title":"Neuropathology"},{"key":"1471_CR90","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3988\/jcn.2022.18.4.437","volume":"18","author":"M Oh","year":"2022","unstructured":"Oh M et al (2022) [18F]THK-5351 PET Patterns in Patients With Alzheimer\u2019s Disease and Negative Amyloid PET Findings. J Clin Neurol 18:437\u2013446","journal-title":"J Clin Neurol"},{"key":"1471_CR91","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1007\/s00415-022-11330-5","volume":"269","author":"NA Singh","year":"2022","unstructured":"Singh NA et al (2022) Atypical Alzheimer\u2019s disease phenotypes with normal or borderline PET biomarker profiles. J Neurol 269:6613\u20136626","journal-title":"J Neurol"},{"key":"1471_CR92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s40478-021-01255-x","volume":"9","author":"BE Stopschinski","year":"2021","unstructured":"Stopschinski BE et al (2021) (2021) Anatomic survey of seeding in Alzheimer\u2019s disease brains reveals unexpected patterns. Acta Neuropathol Commun. 9:164","journal-title":"Acta Neuropathol Commun."},{"key":"1471_CR93","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00005072-198705000-00003","volume":"46","author":"RD Terry","year":"1987","unstructured":"Terry RD et al (1987) Senile dementia of the alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46:262\u2013268","journal-title":"J Neuropathol Exp Neurol"},{"key":"1471_CR94","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-010-0707-9","volume":"120","author":"DR Thal","year":"2010","unstructured":"Thal DR et al (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE \u03b54-associated subtype of sporadic Alzheimer\u2019s disease. Acta Neuropathol 120:169\u2013183","journal-title":"Acta Neuropathol"},{"key":"1471_CR95","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/01.WNL.0000118212.41542.E7","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P et al (2004) Alzheimer disease without neocortical neurofibrillary tangles: \u2018A second look.\u2019 Neurology 62:1141\u20131147","journal-title":"Neurology"},{"key":"1471_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB et al (2016) Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409","journal-title":"Acta Neuropathol"},{"key":"1471_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00304633","volume":"85","author":"P Vermersch","year":"1992","unstructured":"Vermersch P, Frigard B, Delacourte A (1992) Mapping of neurofibrillary degeneration in Alzheimer\u2019s disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol 85:48\u201354","journal-title":"Acta Neuropathol"},{"key":"1471_CR98","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/hbm.24401","volume":"40","author":"JW Vogel","year":"2019","unstructured":"Vogel JW et al (2019) Data-driven approaches for tau-PET imaging biomarkers in Alzheimer\u2019s disease. Hum Brain Mapp 40:638\u2013651","journal-title":"Hum Brain Mapp"},{"key":"1471_CR99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1006\/exnr.1998.6852","volume":"22","author":"BA Vogt","year":"1998","unstructured":"Vogt BA et al (1998) Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer\u2019s disease. Exp Neurol 22:8\u201322","journal-title":"Exp Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01471-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01471-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01471-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T15:28:05Z","timestamp":1701358085000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01471-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01471-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ADNI study was performed in accordance with the ethical standards by the Declaration of Helsinki, and ethics committees at each participating center reviewed and approved data collection and study procedures. All participants \/ their legal guardians gave their informed consent prior to their inclusion in the ADNI study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MEM receives funding from the NIH, Alzheimer\u2019s Association, and the State of Florida; and has served as a paid consultant for AVID Radiopharmaceuticals. KK serves on the data safety monitoring board for Takeda Global Research and Development Center, Inc.; receives research support from Avid Radiopharmaceuticals and Eli Lilly, and receives funding from NIH and Alzheimer\u2019s Drug Discovery Foundation. DF, RM, AN, and EW declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}